bpc-157 multiple sclerosis trial Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats | Journal of Orthopaedic Surgery and Research Stable Gastric Pentadecapeptide BPC 157

If one day your protocol requires a different ratio, you haven't committed an entire vial to a fixed combination

Cancer-related tissue damage BPC-157's angiogenic properties are a theoretical concern in the context of existing tumors

Its short half-life, however, required it to be injected several times a day, which limited its appeal as a drug, and the company ran out of funding

That is where peptides come in

For a more editorial, shorter read on the same protocol, see my piece on drworldwide.com: After the Operating Room: The Peptide Stack My Patients Recover On

RESEARCH USE ONLY Not for human or veterinary use BATCH VERIFIED Research Use Only This product is strictly for in vitro research and laboratory use only